Inbeeo dives into the data from our COVID-19 Impact on Market Access Activities Dashboard and identifies three positive trends that emerged.
The Challenge Inbeeo’s client, a specialty pharmaceutical company, was preparing for the Wave 1 launch of an ‘incremental innovation’ product. They required health economic tools
The Challenge Inbeeo’s client, a large biotech, had received negative recommendations for reimbursement of its novel biologic treatment for severe forms of post-menopausal osteoporosis (PMO).
France’s healthcare industry strategic council CSIS met an agreement with the French Government to strengthen France’s appeal for HealthCare industries. Inbeeo dives in to investigate the impact on market access and pricing.
